A panelist discusses how treating demodex blepharitis with Lotilaner not only eliminates the anterior blepharitis symptoms but also improves meibomian gland function, with low recurrence rates after ...

A panelist discusses how demodex blepharitis frequently co-occurs with other ocular surface conditions in younger patients, as illustrated by a 35-year-old contact lens wearer who presented with ...

Leading eye surgeons tell The i Paper that they have seen a surge in cases of eye disease in the past few years ...

An eye surgeon is warning Brits of a huge rise in a health condition that causes your eyes to swell and become inflamed.

An eye surgeon has warned of a 'massive issue' that is on the rise in the UK, as he urged people to increase the temperature ...

XDEMVY™ (lotilaner ophthalmic solution) 0.25%, is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular ...

XDEMVYTM (lotilaner ophthalmic solution) 0.25%, is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular ...

Lotilaner, approved for Demodex blepharitis, is the only approved treatment, demonstrating high efficacy and strong launch metrics, with $113 million in annual revenue. Despite a Q3 sales dip ...

The company's strategic moves appear to be setting the stage for sustained progress in the treatment of Demodex blepharitis. While analysts project continued sales growth, detailed financial ...

As the first treatment cleared by the FDA for Demodex blepharitis, an eye disease estimated to affect 25 million people in the U.S. alone, Tarsus Pharmaceuticals’ Xdemvy is pitting its might ...

Waking up with some gunk in your eyes is usually nothing to worry about. The scientific name for this crust is rheum, and it forms when oil and other debris collect on your eyelids during sleep.